Your browser doesn't support javascript.
loading
[Clinicopathological features and BRAF V600E and MYD88 L265P mutation status of nodal marginal zone lymphoma].
Wang, X Y; Li, M; Zhao, Y X; Wang, L F; Li, D J; Xu, Z G; Kong, L F.
Afiliação
  • Wang XY; Department of Pathology, Henan Provincial People's Hospital/People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Li M; Department of Pathology, Peking University School of Basic Medical Sciences, Beijing 100191 China.
  • Zhao YX; Department of Pathology, Henan Provincial People's Hospital/People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Wang LF; Department of Pathology, Henan Provincial People's Hospital/People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Li DJ; Department of Pathology, Henan Provincial People's Hospital/People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Xu ZG; Department of Pathology, Henan Provincial People's Hospital/People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Kong LF; Department of Pathology, Henan Provincial People's Hospital/People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
Zhonghua Bing Li Xue Za Zhi ; 51(4): 301-306, 2022 Apr 08.
Article em Zh | MEDLINE | ID: mdl-35359040

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Proteínas Proto-Oncogênicas B-raf / Fator 88 de Diferenciação Mieloide Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Proteínas Proto-Oncogênicas B-raf / Fator 88 de Diferenciação Mieloide Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China